{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:42:18Z","timestamp":1793029338505,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162243"],"award-info":[{"award-number":["PJT-162243"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-180299"],"award-info":[{"award-number":["PJT-180299"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-180300"],"award-info":[{"award-number":["PJT-180300"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nucmedbio.2026.109674","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:52:23Z","timestamp":1786690343000},"page":"109674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and evaluation of [68Ga]Ga-DOTA-Pip-PEP-4 derivatives for imaging gastrin-releasing peptide receptor expression with positron emission tomography"],"prefix":"10.1016","volume":"160-161","author":[{"given":"Sheetal","family":"Pathania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Jozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Sum","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Merkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Shyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109674_bb0005","article-title":"Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1250799","article-title":"GRPR-targeting radiotheranostics for breast cancer management","volume":"10","author":"D\u2019Onofrio","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2967\/jnumed.119.234971","article-title":"Imaging the distribution of gastrin-releasing peptide receptors in cancer","volume":"61","author":"Baratto","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF02145873","article-title":"Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians bombina and alytes","volume":"27","author":"Anastasi","year":"1971","journal-title":"Experientia"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/gut.19.9.767","article-title":"A gastrin-releasing peptide from the porcine nonantral gastric tissue","volume":"19","author":"McDonald","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0030","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1021\/acs.molpharmaceut.4c00066","article-title":"Radiopharmaceuticals targeting gastrin-releasing peptide receptor for diagnosis and therapy of prostate cancer","volume":"21","author":"Zou","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0035","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.semnuclmed.2025.07.003","article-title":"GRPR expression in metastatic cancers: a review of potential application of GRPR-radioligand therapy","volume":"55","author":"Callaud","year":"2025","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-24861-4","article-title":"The gastrin-releasing peptide receptor as a potential biomarker for squamous cell carcinoma","volume":"15","author":"Olguins","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0045","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2967\/jnumed.116.188011","article-title":"Expression of gastrin-releasing peptide receptor in breast cancer and its association with pathologic, biologic, and clinical parameters: a study of 1,432 primary tumors","volume":"58","author":"Morgat","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/acsptsci.5c00491","article-title":"Preclinical evaluation of a 177Lu-labeled gastrin-releasing peptide receptor antagonist and prostate cancer treatment with monotherapy and in combination with everolimus","volume":"9","author":"Kumar","year":"2026","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"Suppl. 2","key":"10.1016\/j.nucmedbio.2026.109674_bb0055","first-page":"79P","article-title":"Molecular imaging of bombesin receptors in various tumors by 68Ga-AMBA PET\/CT: first results","volume":"48","author":"Baum","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0060","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-12-3490","article-title":"In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548","volume":"19","author":"K\u00e4hk\u00f6nen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0065","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7150\/thno.14958","article-title":"Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET","volume":"6","author":"Stoykow","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2967\/jnumed.120.259630","article-title":"PSMA- and GRPR-targeted PET: results from 50 patients with biochemically recurrent prostate cancer","volume":"62","author":"Baratto","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00259-019-04504-3","article-title":"First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer","volume":"47","author":"Kurth","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2967\/jnumed.116.178889","article-title":"Theranostic perspectives in prostate cancer with the gastrin-releasing peptide receptor antagonist NeoBOMB1: preclinical and first clinical results","volume":"58","author":"Nock","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2967\/jnumed.120.257758","article-title":"A radiotracer for molecular imaging and therapy of gastrin-releasing peptide receptor\u2013positive prostate cancer","volume":"63","author":"Bratanovic","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.107.07108","article-title":"International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states","volume":"60","author":"Jensen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0095","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00259-024-06634-9","article-title":"Synthesis, preclinical, and initial clinical evaluation of integrin \u03b1V\u03b23 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03","volume":"51","author":"Wen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0100","doi-asserted-by":"crossref","first-page":"12664","DOI":"10.1073\/pnas.91.26.12664","article-title":"Potent bombesin antagonists with C-terminal Leu-\u03c8(CH2-N)-Tac-NH2 or its derivatives","volume":"91","author":"Cai","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.nucmedbio.2026.109674_bb0105","first-page":"749","article-title":"New antagonists of bombesin gastrin-releasing peptide with C-terminal Leu-\u03c8-(CH2N)Tac-NH2","volume":"7","author":"Reile","year":"1995","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0110","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3390\/molecules27123777","article-title":"68Ga-Labeled [Leu13\u03c8Thz14]Bombesin(7\u201314) derivatives: promising GRPR-targeting PET tracers with low pancreas uptake","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0115","article-title":"68Ga-labeled [Thz14]Bombesin(7\u201314) analogs: promising GRPR-targeting agonist PET tracers with low pancreas uptake","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0120","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1021\/acs.molpharmaceut.4c00952","article-title":"Synthesis and evaluation of 68Ga and 177Lu-labeled [Pro14]Bombesin(8\u201314) derivatives for detection and radioligand therapy of gastrin-releasing peptide receptor-expressing cancer","volume":"21","author":"Wang","year":"2024","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.nucmedbio.2026.109674_bb0125","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1021\/acs.molpharmaceut.5c01683","article-title":"Synthesis and evaluation of novel 68Ga-labeled GRPR-targeted PET tracers derived from [D-Phe6,Pro14]Bombesin(6\u201314) and [D-Phe6,des-Met14]Bombesin(6\u201314) Sequences","volume":"23","author":"Jozi","year":"2026","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/0008-5472.CAN-14-1603","article-title":"In vivo radioimaging of bradykinin receptor B1, a widely overexpressed molecule in human cancer","volume":"75","author":"Lin","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41181-024-00241-7","article-title":"Unnatural amino acid substitutions to improve in vivo stability and tumor uptake of 68Ga-labeled GRPR-targeted TacBOMB2 derivatives for cancer imaging with positron emission tomography","volume":"9","author":"Wang","year":"2024","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0140","article-title":"Synthesis and evaluation of 68Ga and 177Lu-labeled [diF-Pro14]Bombesin(6\u221214) analogs for detection and radioligand therapy of gastrin-releasing peptide receptor-expressing cancer","volume":"18","author":"Wang","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216230120","article-title":"Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy","volume":"120","author":"Peng","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0150","article-title":"Synthesis and evaluation of the first 68Ga-labeled C-terminal hydroxamate-derived gastrin-releasing peptide receptor-targeted tracers for cancer imaging with positron emission tomography","volume":"29","author":"Wang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2026.109674_bb0155","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1021\/acsomega.8b03293","article-title":"Positron emission tomography imaging of the gastrin-releasing peptide receptor with a novel bombesin analogue","volume":"4","author":"Lau","year":"2019","journal-title":"ACS Omega"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:26:54Z","timestamp":1793028414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0969805126000739"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109674","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of [68Ga]Ga-DOTA-Pip-PEP-4 derivatives for imaging gastrin-releasing peptide receptor expression with positron emission tomography","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109674"}}